>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
高尿酸血症与慢性肾脏病发生发展关系的研究进展
作者:张晓敏  刘宏  刘必成 
单位:东南大学附属中大医院 肾内科, 江苏 南京 210009
关键词:高尿酸血症 慢性肾脏病 危险因素 文献综述 
分类号:R589.6;R692
出版年·卷·期(页码):2013·32·第一期(114-117)
摘要:

近年来随着居民生活方式及饮食结构的改变和人口老龄化,高尿酸血症的发病率呈不断上升趋势。高尿酸血症不仅是痛风的主要病因,也是高血压、心血管疾病和糖尿病等发生、发展的独立危险因素,已经成为威胁人类健康的代谢性疾病之一。既往人们认为血尿酸水平升高仅仅是肾功能减退的指标,近年来研究发现,HUA在慢性肾脏病的发生、发展中也发挥重要作用,对血尿酸水平进行早期监测和干预可能对延缓慢性肾脏病进展具有重要意义。

参考文献:

[1] FANG J,ALDERMAN M H.Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study,1971-1992.National Health and Nutrition Examination Survey[J].JAMA,2000,283(18):2404-2410.
[2] ZHU Y,PANDYA B J,CHOI H K.Prevalence of gout and hyperuricemia in the US general population:the National Health and Nutrition Examination Survey 2007-2008[J].Arthritis Rheum,2011,63(10):3136-3141.
[3] ROBINSON P,TAYLOR W,MERRIMAN T.A Systematic Review of the Prevalence of Gout and Hyperuricemia in Australia[J].Intern Med J,2012,.
[4] KAZUFUMI N,KUNITOSHI I,TAKU I,et al.Hyperuricemia and cardiovascular risk factor clustering in a screened cohort in Okinawa,Japan[J].Hypertens Res,2004,27(4):227-233.
[5] LIU B, WANG T,ZHAO H N,et al.The prevalence of hyperuricemia in China:a meta-analysis[J].BMC Public Health,2011,11:832.
[6] KAWANO Y.Uric acid and blood pressure[J].Circ J,2011,75(12):2755-2756.
[7] PUDDU P,PUDDU G M,CRAVERO E,et al.The relationships among hyperuricemia,endothelial dysfunction,and cardiovascular diseases:molecular mechanisms and clinical implications[J].J Cardiol,2012,59(3):235-242.
[8] 张敏,宋秀霞,姜涛.高尿酸血症与代谢综合征的相关性分析[J].中国现代医学杂志,2008,18(5):623-625.
[9] 朱煜,唐汇敏,邓江平,等.原发性高尿酸血症患病率调查[J].东南大学学报:医学版,2007,26(1):41-42.
[10] FILIOPOULOS V,HADJIYANNAKOS D,VLASSOPOULOS D.New insights into uric Acid effects on the progression and prognosis of chronic kidney disease[J].Ren Fail,2012,34(4):510-520.
[11] HSU C Y,IRIBARREN C,McCULLOCH C E,et al.Risk factors for end-stage renal disease:25-year follow-up[J].Arch Intern Med,2009,169(4):342-350.
[12] WEINER D E,TIGHIOUART H,ELSAYED E F,et al.Uric acid and incident kidney disease in the community[J].J Am Soc Nephrol,2008,19(6):1204-1211.
[13] FEIG D I.Uric acid:a novel mediator and marker of risk in chronic kidney disease? [J].Curr Opin Nephrol Hypertens,2009,18(6):526-530.
[14] JOLLY S E,METE M,WANG H,et al.Uric acid,hypertension,and chronic kidney disease among Alaska Eskimos:the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study[J].J Clin Hypertens (Greenwich),2012,14(2):71-77.
[15] OHNO I,HOSOYA T,GOMI H,et al.Serum uric acid and renal prognosis in IgA nephropathy[J].Nephron,2001,87(4):333-339.
[16] CHONCHOL M B,SHLIPAK M G,KATZ R,et al.Relationship of uric acid with progression of kidney disease[J].Am J Kidney Dis,2007,50(2):239-247.
[17] KANBAY M,OZKARA A,SELCOKI Y,et al.Effect of treatment of hyperuricemia with allopurinol on blood pressure,creatinine clearence,and proteinuria in patients with normal renal functions[J].Int Urol Nephrol,2007,39(4):1227-1233.
[18] SIU Y P,LEUNG K T,TONG M K,et al.Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level[J].Am J Kidney Dis,2006,47(1):51-59.
[19] GOICOECHEA M,de VINUESA S G,VERDALLES U,et al.Effect of allopurinol in chronic kidney disease progression and cardiovascular risk[J].Clin J Am Soc Nephrol,2010,5(8):1388-1393.
[20] STURM G,KOLLERITS B,NEYER U,et al.Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease(MMKD) Study[J].Exp Gerontol,2008,43(4):347-352.
[21] ISHANI A,GRANDITS G A,GRIMM R H,et al.Association of single measurements of dipstick proteinuria,estimated glomerular filtration rate,and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial[J].J Am Soc Nephrol,2006,17(5):1444-1452.
[22] MOE O W.Posing the question again:does chronic uric acid nephropathy exist?[J].J Am Soc Nephrol,2010,21(3):395-397.
[23] JIN M,YANG F,YANG I,et al.Uric acid,hyperuricemia and vascular diseases[J].Front Biosci,2012,17:656-669.
[24] KANBAY M,YILMAZ M I,SONMEZ A,et al.Serum uric acid level and endothelial dysfunction in patients with nondiabetic chronic kidney disease[J].Am J Nephrol,2011,33(4):298-304.
[25] YELKEN B,CALISKAN Y,GORGULU N,et al.Reduction of uric acid levels with allopurinol treatment improves endothelial function in patients with chronic kidney disease[J].Clin Nephrol,2012,77(4):275-282.
[26] GHAEMI-OSKOUIE F,SHI Y.The role of uric acid as an endogenous danger signal in immunity and inflammation[J].Curr Rheumatol Rep,2011,13(2):160-166.
[27] JALAL D I,JABLONSKI K L,MCFANN K,et al.Vascular endothelial function is not related to serum uric acid in healthy adults[J].Am J Hypertens,2012,25(4):407-413.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 412054 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364